Advanced search
Publication Cover
Renal Failure Volume 25, 2003 - Issue 5
Submit an article Journal homepage
2,273
Views
19
CrossRef citations to date
0
Altmetric
CLINICAL STUDY

Effects of Manidipine and Nifedipine on Blood Pressure and Renal Function in Patients with Chronic Renal Failure: A Multicenter Randomized Controlled Trial

Guido Bellinghieri Chairs and Division of Nephrology, School of Medicine, University of Messina Viale Gazzi, Messina, Italy
,
Giampiero Mazzaglia The Health Search Database, Florence, Italy
,
Vincenzo Savica Chairs and Division of Nephrology, School of Medicine, University of Messina Viale Gazzi, Messina, Italy
&
Domenico Santoro Chairs and Division of Nephrology, School of Medicine, University of Messina Viale Gazzi, Messina, ItalyCorrespondence[email protected]
, M.D.
Pages 681-689 | Published online: 07 Jul 2009

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

N.R. Robles, B. Romero, E. Garcia de Vinuesa, E. Sánchez-Casado & J.J. Cubero. (2010) Treatment of Proteinuria with Lercanidipine Associated with Renin-Angiotensin Axis-Blocking Drugs. Renal Failure 32:2, pages 192-197.
Read now
Francisco Javier Martinez-Martin & Margarita Saiz-Satjes. (2008) Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study. Expert Review of Cardiovascular Therapy 6:10, pages 1347-1355.
Read now
Nicolás Roberto Robles. (2008) Calcium Antagonists and Renal Failure Progression. Renal Failure 30:3, pages 247-255.
Read now
Antonio Coca. (2007) Manidipine plus delapril in patients with Type 2 diabetes and hypertension: reducing cardiovascular risk and end-organ damage. Expert Review of Cardiovascular Therapy 5:2, pages 147-159.
Read now
Valérie Tikhonoff, Alberto Mazza, Edoardo Casiglia & Achille C Pessina. (2004) Role of manidipine in the management of patients with hypertension. Expert Review of Cardiovascular Therapy 2:6, pages 815-827.
Read now

Articles from other publishers (14)

Kyle H. Moore & John S. Clemmer. (2021) Questioning the renoprotective role of L-type calcium channel blockers in chronic kidney disease using physiological modeling. American Journal of Physiology-Renal Physiology 321:4, pages F548-F557.
Crossref
Kelsey L. Richardson, Donald J. WeaverJrJr, Derek K. Ng, Megan K. Carroll, Susan L. Furth, Bradley A. Warady & Joseph T. Flynn. (2021) L-type calcium channel blocker use and proteinuria among children with chronic kidney diseases. Pediatric Nephrology 36:8, pages 2411-2419.
Crossref
Nicolás R Robles, Francesco Fici & Guido Grassi. (2016) Dihydropyridine calcium channel blockers and renal disease. Hypertension Research 40:1, pages 21-28.
Crossref
Margarita Saiz Satjes & Francisco J Martinez-Martin. (2016) Treatment of hypertensive patients with diabetes: beyond blood pressure control and focus on manidipine. Future Cardiology 12:4, pages 435-447.
Crossref
Xue Li & Mao Sheng Yang. (2014) Effects of T-Type Calcium Channel Blockers on Renal Function and Aldosterone in Patients with Hypertension: A Systematic Review and Meta-Analysis. PLoS ONE 9:10, pages e109834.
Crossref
Christian Ott, Markus P. Schneider, Ulrike Raff, Martin Ritt, Kristina Striepe, Marco Alberici & Roland E. Schmieder. (2013) Effects of manidipine vs. amlodipine on intrarenal haemodynamics in patients with arterial hypertension . British Journal of Clinical Pharmacology 75:1, pages 129-135.
Crossref
Nicolás R. Robles & Roman Hernandez-Gallego. (2012) Blood Pressure in Renal Disease: How to Accomplish the Goal?. Cardiovascular Therapeutics 30:4, pages 193-198.
Crossref
N. R. Robles, B. Romero, E. Garcia de Vinuesa, E. Sánchez-Casado & J. J. Cubero. (2011) Treatment of proteinuria with lercanidipine associated with reninangiotensin axis-blocking drugs. Cardiovascular Therapy and Prevention 10:3, pages 83-88.
Crossref
Francisco J. Martinez-Martin, Alicia Macias-Batista, Cristina Comi-Diaz, Herminia Rodriguez-Rosas, Paula Soriano-Perera & Pablo Pedrianes-Martin. (2011) Effects of Manidipine and its Combination with an ACE Inhibitor on Insulin Sensitivity and Metabolic, Inflammatory and Prothrombotic Markers in Hypertensive Patients with Metabolic Syndrome. Clinical Drug Investigation 31:3, pages 201-212.
Crossref
Luca Cavalieri & Giovanni Cremonesi. (2012) Metabolic Effects of Manidipine. American Journal of Cardiovascular Drugs 9:3, pages 163-176.
Crossref
Alberto Zanchetti. (2005) Closing Remarks: Current Position of Calcium Channel Antagonists in Hypertension ??? the Role of Manidipine. Drugs 65:Suppl 2, pages 40???42.
Crossref
Ren?? R Wenzel. (2005) Renal Protection in Hypertensive Patients: Selection of Antihypertensive Therapy. Drugs 65:Suppl 2, pages 29???39.
Crossref
Alex Roca-Cusachs & Filippos Triposkiadis. (2005) Antihypertensive Effect of Manidipine. Drugs 65:Suppl 2, pages 11???19.
Crossref
Kate McKeage & Lesley J Scott. (2004) Manidipine. Drugs 64:17, pages 1923-1940.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.